Sabra Health Care REIT (SBRA) Pulls Back Despite SHOP Focus, Is It Still Below Fair Value?
Sabra Health Care REIT (SBRA) has been drawing attention after recent share price swings. The stock closed at US$19.56 as investors reassess its healthcare-focused real estate portfolio across the United States and Canada.
Recent trading tells a mixed story for Sabra Health Care REIT. The share price has slipped about 13% over the past three months, even though the year-to-date share price return is slightly positive. Meanwhile, the 1-year total shareholder return of 14.92% points to momentum that has been driven more by income and reinvested payouts than by short-term price action alone.
Scan Sabra Health Care REIT alongside other income-focused real estate plays by checking our curated list of 5 dividend fortresses.
Given Sabra Health Care REIT’s recent pullback against a stronger 1-year total return, should you lean into the current price or wait for a deeper discount as the valuation picture becomes clearer?
Most Popular Narrative: 14% Undervalued
On the most followed view of Sabra Health Care REIT, a fair value of $22.79 sits above the last close at $19.56. This puts the recent pullback in a different light for anyone focused on long term cash flow potential rather than just the last quarter of price action.
Continued shift of Sabra Health Care REIT’s investment pipeline toward managed senior housing, with over 95% of more than US$1b of active opportunities tied to SHOP assets and 21 assets added year over year, can keep raising private pay exposure and support future revenue and cash NOI growth.
See why 8 investors see Sabra Health Care REIT as 14% undervalued.
Result: Fair Value of $22.79 (UNDERVALUED)
However, Sabra Health Care REIT still carries execution risk around operator transitions and a cash-hungry SHOP pipeline that could pressure both earnings momentum and dividend capacity.
Find out about the key risks to this Sabra Health Care REIT narrative.
Another View: What Multiples Say About Sabra Health Care REIT
The first narrative leans on cash flows and a fair value of $22.79 for Sabra Health Care REIT. A different lens comes from the current P/E of 76.4x, which looks rich against a fair ratio of 49.8x, a 48.3x peer average and a 17.5x industry level. That kind of gap points to valuation risk rather than a clear bargain. Which signal do you weigh more heavily right now?
See what the numbers say about this price in our valuation breakdown, starting with See what the numbers say about this price — find out in our valuation breakdown..
Next Steps
Mixed messages in the Sabra Health Care REIT story so far. If you want to move quickly and decide where you stand, weigh the 2 key rewards and 4 important warning signs.
Looking for more investment ideas beyond Sabra Health Care REIT?
You have a clear picture of Sabra Health Care REIT. Now protect your edge by lining up a few more candidates before the market moves on without you.
- Target potential mispricings and widen your opportunity set by scanning our list of 29 high quality undervalued stocks.
- Strengthen the defensive side of your portfolio by focusing on companies with robust finances through this list of solid balance sheet and fundamentals (24 results).
- Get ahead of the crowd by reviewing a curated pool of 21 high quality undiscovered gems.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com